Author

Maria Sola Soto

Institution: Vall d'Hebron Hospital Universitari

Observed institutions: Universitat Autònoma de Barcelona, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology

OpenAlex ID: A5111084511

Safety and feasibility of 0.6 mg/kg every 4 weeks dosing of axatilimab in patients treated in the AGAVE-201 study

2025 · Nosha Farhadfar, Maria Sola Soto, et al. · Blood · 1

Safety and Feasibility of 0.6 Mg/Kg Every 4 Weeks Dosing of Axatilimab in Patients Treated in the AGAVE-201 Study

2026 · Nosha Farhadfar, Maria Sola Soto, et al. · Transplantation and Cellular Therapy

Impact of Antibacterial Prophylaxis on Morbidity-Mortality of Patients with Myeloid Neoplasms Treated with Non-Intensive Venetoclax Combinations

2023 · Sara Garrido Paniagua, Sandra Novoa Jáuregui, et al. · Blood

Works count: 3

Citation count: 1

H-index: 1

I10-index: